you are here: HomeNewsBusiness

USCIS to begin premium processing of H-1B visas, green cards in phases from June 1, 2020

USCIS suspended temporarily premium processing for H-1B visas and employment-based green cards due to COVID-19 outbreak.

May 29, 2020 / 11:12 PM IST

United States Citizenship and Immigration Services (USCIS) will resume premium processing of H-1B petitions and employment-based green card petitions in phases from June 1, 2020.

On March 20, USCIS suspended temporarily premium processing for all Form I-129 (H-1B) and I-140 petitions (employment-based green card applications) due to the COVID-19 outbreak.

"USCIS continues to process any petition with a previously accepted Form I-907 (request for premium processing), in accordance with the premium processing service criteria," it said in a statement.

On June 1, premium processing will begin for all eligible employment-based green card petitions. From June 8, H-1B petitions that are pending adjudication and those that are cap-exempt, which are jobs exempt from the annual cap on foreign workers holding H-1B visa.

Current H-1B petitions that are cap-exempt will start on June 15 and starting June 22, premium processing of all other H-1B petitions will begin.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"All H-1B cap-subject petitions (including those for fiscal year 2021), including change of status from F-1 nonimmigrant status, for both premium processing upgrades and concurrently filed I-907s," the statement added.

These dates are subject to change, USCIS said.

"Petitioners who had already filed Form I-129 or Form I-140 using the premium processing service before the March 20 suspension, but received no action and a refund, may refile their Form I-907 consistent with the timeline above, barring any changes USCIS may announce in the future,” the statement further added.

Follow our full coverage of the coronavirus outbreak here
Moneycontrol News
first published: May 29, 2020 11:12 pm

stay updated

Get Daily News on your Browser
Sections